The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 53 | — | 20.1x | Near average | |
Growth | 82 | 100.0% | 5.6% | Above average | |
Quality | 9 | -192.0% | 7.6% | Below average | |
Safety | 65 | 1.4x | 0.4x | Near average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Amylyx Pharmaceuticals, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Amylyx Pharmaceuticals, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
The data shows complete stability in the average price target for Amylyx at 24.5 dollars over the past 7 and 30-day periods, with a consensus from 7 analysts and no recent adjustments in recommendations. This stability indicates a state of anticipation for new catalysts, especially since the current price (13.58 dollars) is trading at a significant discount to the lowest observed price target (21 dollars), reflecting technical optimism for upside targets despite the absence of immediate momentum.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.